The Alcohol Dependence drugs in development market research report provides comprehensive information on the therapeutics under development for Alcohol Dependence, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Alcohol Dependence. Buy the report here.
Smarter leaders trust GlobalData
The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Alcohol Dependence and features dormant and discontinued products.
GlobalData tracks 78 drugs in development for Alcohol Dependence by 67 companies/universities/institutes. The top development phase for Alcohol Dependence is preclinical with 39 drugs in that stage. The Alcohol Dependence pipeline has 71 drugs in development by companies and seven by universities/ institutes. Some of the companies in the Alcohol Dependence pipeline products market are: BioCorRx, Camino Pharma and Corcept Therapeutics.
The key targets in the Alcohol Dependence pipeline products market include 5-Hydroxytryptamine Receptor 2A (5 HT2A or Serotonin Receptor 2A or HTR2A), Mu Type Opioid Receptor (MOR1 or Mu Opiate Receptor or Mu Opioid Receptor or OPRM1), and 5-Hydroxytryptamine Receptor 1A (5 HT1A or G 21 or Serotonin Receptor 1A or HTR1A).
The key mechanisms of action in the Alcohol Dependence pipeline product include 5-Hydroxytryptamine Receptor 2A (5 HT2A or Serotonin Receptor 2A or HTR2A) Agonist with nine drugs in Phase II. The Alcohol Dependence pipeline products include eight routes of administration with the top ROA being Oral and four key molecule types in the Alcohol Dependence pipeline products market including Small Molecule, and Antisense RNAi Oligonucleotide.
Alcohol Dependence overview
Alcohol addiction refers to a psychological and physical dependency on alcohol. Symptoms include decreased involvement in extracurricular activities, depression, restlessness, inability to control drinking, and violent behavior. Risk factors include age, family history, and depression or other mental health problems.
For a complete picture of Alcohol Dependence’s pipeline drug market, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s pipeline drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval proprietary and is one of two primary repositories of pharmaceutical drug information offered by GlobalData through its Pharmaceutical Intelligence Center.
